ALPHARETTA, Ga.--(BUSINESS WIRE)--May 17, 2006--First Horizon Pharmaceutical Corporation (NASDAQ: FHRX - News), a specialty pharmaceutical company, today announced that the chairman of its Board of Directors, Dr. John N. Kapoor, through an arrangement with UBS Investment Bank, has sold 1 million shares of the Company’s common stock held in various trusts benefiting his family members and by Kapoor Pharma Investments L.P. The Rule 144 sale was conducted as part of an overall plan by Dr. Kapoor to diversify his various securities holdings.
